 <h1>Aliskiren / amlodipine / hydrochlorothiazide Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to aliskiren/amlodipine/hydrochlorothiazide: oral tablet</i></p><h3>Cardiovascular</h3><p>Aliskiren:</p><p><b>Rare</b> (less than 0.1%): Hypotension</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): palpitations</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, hypotension, peripheral ischemia, postural hypotension, tachycardia, vasculitis</p><p><b>Rare</b> (less than 0.1%): Myocardial infarction, angina</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Cardiac arrhythmias (including ventricular ectopy and complete AV heart block), hypotension, orthostatic hypotension (more common in the elderly)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Aliskiren:</p><p><b>Common</b> (1% to 10%): Rash</p><p><b>Rare</b> (less than 0.1%): Angioedema (involving the face, hands, or whole body)</p><p><b>Postmarketing reports</b>: Severe cutaneous adverse reactions (including Stevens Johnson syndrome and toxic epidermal necrolysis)</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Rash, erythematous rash</p><p><b>Uncommon</b> (0.1% to 1%): Angioedema, erythema multiforme, increased sweating, maculopapular rash, pruritus</p><p><b>Rare</b> (less than 0.1%): Alopecia, dermatitis, skin discoloration, skin dryness, urticaria, lichen planus, telangiectasia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Rare</b> (less than 0.1%): Erythema annular centrifugum, acute eczematous dermatitis, morbilliform and leukocytoclastic vasculitis, phototoxic dermatitis</p><p><b>Frequency not reported</b>: Subacute cutaneous lupus erythematosus like reaction<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Amlodipine:</p><p><b>Postmarketing reports</b>: Gynecomastia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Aliskiren:</p><p><b>Common</b> (1% to 10%): Diarrhea, abdominal pain, dyspepsia, gastroesophageal reflux (these side effects appear to be dose related)</p><p><b>Postmarketing reports</b>: Nausea, vomiting</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Nausea, dysphagia, abdominal pain</p><p><b>Uncommon</b> (0.1% to 1%): Anorexia, constipation, diarrhea, dry mouth, dyspepsia, flatulence, gingival hyperplasia, pancreatitis, vomiting</p><p><b>Rare</b> (less than 0.1%): Gastritis, increased appetite, loose stools, taste perversion, dysgeusia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Nausea, vomiting, diarrhea<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Micturition disorder, micturition frequency, nocturia</p><p><b>Rare</b> (less than 0.1%): Dysuria, polyuria<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Leukopenia, purpura, thrombocytopenia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Rare</b> (less than 0.1%): Immune-complex hemolytic anemia, aplastic anemia, thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Occasional elevations (greater than 150% from baseline) in ALT (SGPT)</p><p></p><p>Amlodipine:</p><p><b>Postmarketing reports</b>: Jaundice and hepatic enzyme elevations (mostly consistent with cholestasis or hepatitis)-Some cases were severe enough to require hospitalization </p><p></p><p>Hydrochlorothiazide:</p><p><b>Rare</b> (less than 0.1%): Interstitial nephritis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Aliskiren:</p><p><b>Frequency not reported</b>: Angioedema (face, hands, and body) with or without respiratory symptoms</p><p><b>Postmarketing reports</b>: Angioedema</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Rash </p><p><b>Rare</b> (less than 0.1%): Anaphylaxis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very rare</b> (less than 0.01%): Hot flushes</p><p><b>Frequency not reported</b>: Edema, peripheral edema</p><p></p><p>Aliskiren:</p><p><b>Uncommon</b> (0.1% to 1%): Elevated uric acid, gout, renal stones</p><p><b>Postmarketing reports</b>: Peripheral edema, hyponatremia</p><p></p><p>Uric acid increase greater than 50% from baseline was more commonly observed in patients treated with aliskiren / amlodipine / hydrochlorothiazide (4.7%) compared with the dual combinations (0.4 to 2.8%).  Gout was less commonly observed (0.3% in aliskiren / amlodipine / hydrochlorothiazide treated patients) and renal stones were not reported.</p><p></p><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Hyperglycemia, thirst, weight loss, weight gain</p><p><b>Very rare</b> (less than 0.01%): Acute porphyria exacerbation</p><p><b>Frequency not reported</b>: New-onset diabetes </p><p></p><p>Hydrochlorothiazide:</p><p><b>Very common</b> (10% or more): Mild hypokalemia (decrease of 0.5 mEq/L) occurs in up to 50% of patients, and may predispose patients to cardiac arrhythmias</p><p><b>Common</b> (1% to 10%): Metabolic alkalosis, hyponatremia, hypomagnesemia, hypercalcemia, hyperglycemia, elevated serum uric acid levels</p><p><b>Very rare</b> (less than 0.01%): Hot flushes</p><p><b>Frequency not reported</b>: Edema, peripheral edema, glucose intolerance, a potentially deleterious effect on the lipid profile (i.e., increased serum cholesterol)<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Rash that is histologically identical to subacute cutaneous lupus</p><p><b>Frequency not reported</b>: Allergic vasculitis, hemolytic anemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Malaise, pain</p><p><b>Frequency not reported</b>: Fatigue</p><p></p><p>Aliskiren:</p><p><b>Frequency not reported</b>: Headache, dizziness, fatigue, episodes of tonic-clonic seizures with loss of consciousness</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Headache, dizziness, somnolence</p><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, paresthesia, peripheral neuropathy, postural dizziness, syncope, tinnitus, tremor</p><p><b>Rare</b> (less than 0.1%): Migraine</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Cerebrovascular insufficiency associated with hydrochlorothiazide-induced plasma volume contraction, cognitive and neurologic impairment (i.e., confusion, somnolence, feeling dazed)- Symptoms resolved following discontinuation of hydrochlorothiazide.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Asthenia, rigors</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia, arthrosis, muscle cramps</p><p><b>Rare</b> (less than 0.1%): Hypertonia, muscle weakness, twitching, ataxia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Myalgias, chills, muscle spasms, preservation of mineral bone density in older patients<sup>[Ref]</sup></p><h3>Ocular</h3><p>Amlodipine:</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain</p><p><b>Rare</b> (less than 0.1%): Abnormal visual accommodation, xerophthalmia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Transient blurred vision, acute transient myopia, acute angle-closure glaucoma, xanthopsia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Rare</b> (less than 0.1%): Parosmia</p><p><b>Frequency not reported</b>: Tinnitus<sup>[Ref]</sup></p><h3>Renal</h3><p>Amlodipine:</p><p><b>Rare</b> (less than 0.1%): Interstitial nephritis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Rare</b> (less than 0.1%): Renal insufficiency, renal failure, renal dysfunction, interstitial nephritis<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Aliskiren:</p><p><b>Frequency not reported</b>: Nasopharyngitis, upper respiratory tract infection, cough</p><p></p><p>Amlodipine:</p><p><b>Common</b> (1% to 10%): Epistaxis</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Rare</b> (less than 0.1%): Coughing, rhinitis</p><p><b>Postmarketing reports</b>: Pulmonary edema was reported during a study of patients with NYHA Class III or IV heart failure without clinical symptoms or objective evidence of underlying ischemic disease.</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Acute noncardiogenic pulmonary edema (these cases are thought to be due to idiosyncrasy or a hypersensitivity mechanism)<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Amturnide (aliskiren / amlodipine / hydrochlorothiazide)." Novartis Pharmaceuticals, East Hanover, NJ. </p><h2>More about aliskiren / amlodipine / hydrochlorothiazide</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: miscellaneous antihypertensive combinations</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>